Windlas Biotech Limited (WINDLAS.NS) NSE

781.00

-9.15(-1.16%)

Updated at December 05 09:50AM

Currency In INR

Windlas Biotech Limited

Address

705-706, Vatika Professional Point

Gurugram, 122001

India

Phone

91 12 4282 1030

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1154

First IPO Date

August 16, 2021

Key Executives

NameTitlePayYear Born
Ms. Komal GuptaChief Financial Officer & Chief Executive Officer21.26MN/A
Mr. Ananta Narayan PandaCompany Secretary & Compliance Officer3.01MN/A
Mr. Pawan Kumar SharmaExecutive Director8.46M1960
Mr. Ashok Kumar WindlassWhole-Time Director15.6M1950
Mr. Manoj Kumar WindlassJoint MD & Executive Director17.7M1978
Mr. Hitesh WindlassMD & Executive Director17.7M1977
Mr. Om Prakash SuleSite Quality Head0N/A
Mr. Mohammed AslamPresident of Sales & Marketing0N/A

Description

Windlas Biotech Limited operates as a contract development and manufacturing organization (CDMO). Its CDMO services include product discovery, product development, licensing, and commercial manufacturing generic products, including generic products. The company provides its CMDO products and services across a range of pharmaceutical and nutraceutical conventional, and novel products for customers who market such products under their own brand names to the end users. It also offers manufactures various domestic trade generics and over-the-counter brand product portfolio to cater to nutritional, ayurvedic, wellness, and personal care markets. The company's domestic trade generics and OTC brands products are distributed through the offline channel, such as distributors, stockists, retail pharmacies, and institutional tenders, as well as the online channel, such as various e-commerce platforms. It exports its products primarily to Vietnam, Myanmar, Sri Lanka, Thailand, the Philippines, Cambodia, Fiji, Trinidad & Tobago, and South Africa. The company was incorporated in 2001 and is based in Gurugram, India.